Navigation Links
GW Pharmaceuticals to Report Q3 2013 Results and Host Conference Call on 5 August, 2013
Date:7/15/2013

LONDON, July 15, 2013 /PRNewswire/ -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or "the Company"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, will announce on 5 August 2013 its financial results for the third quarter ending 30 June, 2013. GW will also host a conference call the same day at 1:00 p.m. BST (8:00 a.m. EDT).

Conference call information will be provided in the financial results press release. A replay of the call will also be available through the Company's website (www.gwpharm.com) shortly after the call.

About GW Pharmaceuticals plc

Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. GW commercialized the world's first plant-derived cannabinoid prescription drug, Sativex®, which is approved for the treatment of spasticity due to multiple sclerosis in 21 countries. Sativex is also in Phase 3 clinical development as a potential treatment of pain in people with advanced cancer. This Phase 3 program is intended to support the submission of a New Drug Application for Sativex in cancer pain with the U.S. Food and Drug Administration and in other markets around the world. GW has established a world leading position in the development of plant-derived cannabinoid therapeutics and has a deep pipeline of additional cannabinoid product candidates, including two distinct compounds, GWP42004 and GWP42003, in Phase 2 clinical development for Type 2 diabetes and ulcerative colitis, respectively, and at least two additional programs expected to enter Phase 1 and Phase 2 clinical trials in the next 12 months. For further information, please visit www.gwpharm.com. '/>"/>

SOURCE GW Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... , June 29, 2015 BiondVax ... preliminary results from its BVX-006 Phase II clinical trial ... In this trial, M-001 was injected intramuscularly to volunteers ... an administration of the 2014/15 season trivalent influenza vaccine ... safe and well tolerated and induced humoral immune responses, ...
(Date:6/29/2015)... 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... Russell 1000 Index, effective June 26, 2015. The Russell ... of the U.S. equity universe. It is a subset ... of the largest securities based on a combination of ... "We are pleased to be added to this important ...
(Date:6/29/2015)... SAN JOSE, Calif. , June 29, 2015 ... its expert medical workstation lineup. The high-powered, multi-functional ... th generation Intel® Haswell Core ... processor. Both provide significant data processing and computing ... visual performance, making the unit well suited for ...
Breaking Medicine Technology:BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 3ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
... , SAN FRANCISCO, Sept. 14 ... reported long-term data with vicriviroc, its investigational CCR5 receptor ... II VICTOR-E1 study in treatment-experienced HIV-infected patients. The ... durable virologic suppression and increased CD4 cell counts, and ...
... September 14 , - ... Ensure Patient Safety and Quality, Safeguard Hospital Reimbursement , ... and leading provider of advanced,solutions for healthcare that utilize ... integrated group of,hospitals and physician practices, will roll out ...
Cached Medicine Technology:Schering-Plough Reports Long-Term Vicriviroc Data From Phase II Open-Label Extension Study in Treatment-Experienced HIV-Infected Patients 2Schering-Plough Reports Long-Term Vicriviroc Data From Phase II Open-Label Extension Study in Treatment-Experienced HIV-Infected Patients 3Schering-Plough Reports Long-Term Vicriviroc Data From Phase II Open-Label Extension Study in Treatment-Experienced HIV-Infected Patients 4Schering-Plough Reports Long-Term Vicriviroc Data From Phase II Open-Label Extension Study in Treatment-Experienced HIV-Infected Patients 5Novant Health Rolls Out MEDai's Predictive Modeling Solution to Nine Hospitals in Three States 2Novant Health Rolls Out MEDai's Predictive Modeling Solution to Nine Hospitals in Three States 3Novant Health Rolls Out MEDai's Predictive Modeling Solution to Nine Hospitals in Three States 4
(Date:6/29/2015)... ... , ... Sublime Beauty NATURALS® introduces its new USDA Certified Organic Sesame Oil ... skincare and even culinary uses, was especially designed for Oil Pulling. , To ... Pulling can accomplish this. Oil Pulling is an Ayurvedic practice that is easy and ...
(Date:6/29/2015)... ... , ... Aespala Medspa and Plastic Surgery is proud to introduce the newest ... Dr. Dreyfuss received his medical degree from Emory University in Atlanta before completing a ... Fellowship at the University of Chicago. He has taught and practiced medicine in the ...
(Date:6/29/2015)... ... June 30, 2015 , ... Ticket Down is a reputable source for ... 4th of July weekend. Concertgoers can add promo/coupon code GRATEFUL-DEAD-2015 for added savings. ... to their innovative sound, will not want to miss what is sure to be ...
(Date:6/29/2015)... ... June 30, 2015 , ... ... of revised Guidelines for Neuro Musculoskeletal Thermography and Sympathetic Skin Response Studies.* , ... that were first published in 2006, are intended to aid physicians and thermal ...
(Date:6/29/2015)... ... ... An upcoming documentary for public television by the Sports Conflict Institute ... perspective on conflict in sports with guest speakers including sports culture and marketing guru ... the sports industry that will discuss challenges in competitive sports and how sports can ...
Breaking Medicine News(10 mins):Health News:New Product: Transform Wellness and Oral Health With This Ancient Ayurvedic Secret and Organic Product from Sublime Beauty NATURALS® 2Health News:Aespala Medspa and Plastic Surgery Welcomes New Plastic Surgeon to Oak Brook, IL Office 2Health News:Aespala Medspa and Plastic Surgery Welcomes New Plastic Surgeon to Oak Brook, IL Office 3Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Tickets Prices in Chicago at Soldier Field 2Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Tickets Prices in Chicago at Soldier Field 3Health News:American Academy of Thermology Publishes Revised 2015 Guidelines for Neuro-Musculoskeletal Thermography and Sympathetic Skin Response Studies 2Health News:American Academy of Thermology Publishes Revised 2015 Guidelines for Neuro-Musculoskeletal Thermography and Sympathetic Skin Response Studies 3Health News:Dr. Marc Williams Joins SCI and In America Sports Documentary 2Health News:Dr. Marc Williams Joins SCI and In America Sports Documentary 3
... of man. Often it is mistaken for manliness //and other ... to the size of the fingers in a man’s hand?,A ... just that. ,Finger length ratio is the ratio ... ring finger. The study says lower finger ratios are thought ...
... According to a recent study researchers say hunger may be ... researchers // studied 16 men who agreed to skip breakfast. ... evening. Participants were asked to consume sugary, salty or bitter ... not swallow the drinks, but instead spit them out after ...
... causes inflammation of the liver and can cause complications ... countries, the hepatitis B vaccine is recommended for infants. ... protects against infection for up to 10 years. However, ... past 10 years. ,Researchers followed eight-hundred-and-forty-one Alaska natives ...
... is a sleep disorder where a person's breathing stops or ... collapsed airway. This can result in a number of serious ... nine-times more likely to have diabetes than those without the ... researchers say patients with type 2 diabetes who also suffer ...
... that Autism had been on the rise in Japan, even after ... children. ,MMR vaccine is one of the must-have vaccines ... by WHO. ,An edition of the journal Lancet in 1998 ... autism in children. Based on the report, there had been considerable ...
... show that certain form of herpes virus called Kaposi sarcoma– ... be treated with by glycyrrhizic acid (GA) for total recovery. ... can cause cancer by lying suppressed in the infected cells ... to treat all sorts of viral infections, which prevents or ...
Cached Medicine News:
... sophisticated Aumated Immunoassay Analyzer that fits in any ... 16 X 16 X 21 inches and weighs ... for physician office laboratories, work stations for small ... well as a dedicated system for specialty testing. ...
... ECi brings true automation and continuous ... Highly sensitive assays for thyroid, anemia, ... metabolism testing are currently available, with ... Vitros ECi can simultaneously process 60 ...
... the Therapeutic Drug Monitoring Market in 1981 ... in use today, this system uses technology ... measure serum drug concentration in a patient. ... different diseases, often exhibit a narrow therapeutic ...
Architect i2000 is a flexible solution for your evolving laboratory providing high throughput and walkaway time with built-in flexibility....
Medicine Products: